Stempoint Capital’s Ambrx Biopharma Inc AMAM Stock Holding History

Stempoint Capital’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-126,101	Closed	-$1.8M	–	101
2023 Q4	$1.8M	Buy	+126,101	New	+$1.43M	0.48%	52

Stempoint Capital's AMAM Position: Q1 2024 in Review

Stempoint Capital sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 126,101 shares — an estimated $1.8M sold.

Stempoint Capital first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $1.8M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Stempoint Capital reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Stempoint Capital sold 126,101 Ambrx Biopharma Inc shares in Q1 2024, an estimated $1.8M.
Stempoint Capital first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Stempoint Capital's Ambrx Biopharma Inc position peaked at $1.8M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Stempoint Capital's 13F filing for Q1 2024, filed 14 May 2024.